{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:09:45Z","timestamp":1770235785761,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09625-6","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T22:16:05Z","timestamp":1745273765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The urease E subunit vaccine stimulate the immune response versus Helicobacter pylori in animal model"],"prefix":"10.1007","volume":"73","author":[{"given":"Maedeh","family":"Nikzad-Chaleshtori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golnoosh","family":"Rezaeizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faranak","family":"Aali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Doosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"issue":"3","key":"9625_CR1","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3748\/wjg.v20.i3.684","volume":"20","author":"MI Pereira","year":"2014","unstructured":"Pereira MI, Medeiros JA. Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas. World J Gastroenterol: WJG. 2014;20(3):684.","journal-title":"World J Gastroenterol: WJG"},{"key":"9625_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12038-020-00078-7","volume":"45","author":"A Saxena","year":"2020","unstructured":"Saxena A, Mukhopadhyay AK, Nandi SP. Helicobacter pylori: perturbation and restoration of gut microbiome. J Biosci. 2020;45:1\u201315.","journal-title":"J Biosci"},{"issue":"4","key":"9625_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","volume":"43","author":"I Thung","year":"2016","unstructured":"Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, Valasek MA. the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43(4):514\u201333.","journal-title":"Aliment Pharmacol Ther"},{"key":"9625_CR4","doi-asserted-by":"publisher","first-page":"656439","DOI":"10.3389\/fmolb.2021.656439","volume":"8","author":"R Matos","year":"2021","unstructured":"Matos R, Amorim I, Magalh\u00e3es A, Haesebrouck F, G\u00e4rtner F, Reis CA. Adhesion of Helicobacter species to the human gastric mucosa: a deep look into glycans role. Front Mol Biosci. 2021;8:656439.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"9625_CR5","doi-asserted-by":"publisher","first-page":"e12758","DOI":"10.1111\/hel.12758","volume":"26","author":"JL BangaNdzouboukou","year":"2021","unstructured":"BangaNdzouboukou JL, Lei Q, Ullah N, Zhang Y, Hao L, Fan X. Helicobacter pylori adhesins: HpaA a potential antigen in experimental vaccines for H pylori. Helicobacter. 2021;26(1):e12758.","journal-title":"Helicobacter."},{"issue":"11","key":"9625_CR6","doi-asserted-by":"publisher","first-page":"e15042","DOI":"10.1371\/journal.pone.0015042","volume":"5","author":"TD Schoep","year":"2010","unstructured":"Schoep TD, Fulurija A, Good F, Lu W, Himbeck RP, Schwan C, Marshall BJ. Surface properties of Helicobacter pylori urease complex are essential for persistence. PLoS One. 2010;5(11):e15042.","journal-title":"PLoS One."},{"issue":"2","key":"9625_CR7","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1128\/IAI.74.2.920-926.2006","volume":"74","author":"E Carlsohn","year":"2006","unstructured":"Carlsohn E, Nystr\u00f6m J, B\u00f6lin I, Nilsson CL, Svennerholm AM. HpaA is essential for Helicobacter pylori colonization in mice. Infect Immun. 2006;74(2):920\u20136.","journal-title":"Infect Immun"},{"key":"9625_CR8","doi-asserted-by":"publisher","first-page":"344572","DOI":"10.3389\/fimmu.2018.01003","volume":"9","author":"X Pan","year":"2018","unstructured":"Pan X, Pan L. Protection against Helicobacter pylori infection in BALB\/c mouse model by oral administration of multivalent epitope-based vaccine of cholera toxin B subunit-HUUC. Front Immunol. 2018;9:344572.","journal-title":"Front Immunol"},{"issue":"16","key":"9625_CR9","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1128\/JB.185.16.4787-4795.2003","volume":"185","author":"S Benoit","year":"2003","unstructured":"Benoit S, Maier RJ. Dependence of Helicobacter pylori urease activity on the nickel-sequestering ability of the UreE accessory protein. J Bacteriol. 2003;185(16):4787\u201395.","journal-title":"J Bacteriol"},{"issue":"4","key":"9625_CR10","doi-asserted-by":"publisher","first-page":"e12386","DOI":"10.1111\/hel.12386","volume":"22","author":"S Ansari","year":"2017","unstructured":"Ansari S, Yamaoka Y. Survival of Helicobacter pylori in gastric acidic territory. Helicobacter. 2017;22(4):e12386.","journal-title":"Helicobacter"},{"issue":"28\u201329","key":"9625_CR11","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1016\/S0264-410X(01)00119-0","volume":"19","author":"MH Lee","year":"2001","unstructured":"Lee MH, Roussel Y, Wilks M, Tabaqchali S. Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H pylori infection in mice. Vaccine. 2001;19(28\u201329):3927\u201335.","journal-title":"Vaccine."},{"key":"9625_CR12","doi-asserted-by":"crossref","unstructured":"Rahimi E, Ameri M, Doosti A, Gholampour AR. Occurrence of toxigenic Vibrio parahaemolyticus strains in shrimp in Iran. Foodborne Pathog Dis. 2010;7(9):1107\u201311.","DOI":"10.1089\/fpd.2010.0554"},{"key":"9625_CR13","doi-asserted-by":"crossref","unstructured":"Mej\u00edas-Luque R., & Gerhard M. (2017). Immune evasion strategies and persistence of Helicobacter pylori. Molecular Pathogenesis and Signal Transduction by Helicobacter pylori. 53\u201371","DOI":"10.1007\/978-3-319-50520-6_3"},{"key":"9625_CR14","doi-asserted-by":"publisher","first-page":"645210","DOI":"10.3389\/fimmu.2021.645210","volume":"12","author":"P Rosenbaum","year":"2021","unstructured":"Rosenbaum P, Tchitchek N, Joly C, Rodriguez Pozo A, Stimmer L, Langlois S, Martinon F. Vaccine inoculation route modulates early immunity and consequently antigen-specific immune response. Frontiers Immunol. 2021;12:645210.","journal-title":"Frontiers Immunol"},{"issue":"2","key":"9625_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10142-023-01031-1","volume":"23","author":"M Chehelgerdi","year":"2023","unstructured":"Chehelgerdi M, Heidarnia F, Dehkordi FB, Chehelgerdi M, Khayati S, Khorramian-Ghahfarokhi M, Kabiri H. Immunoinformatic prediction of potential immunodominant epitopes from cagW in order to investigate protection against Helicobacter pylori infection based on experimental consequences. Funct Integr Genom. 2023;23(2):107.","journal-title":"Funct Integr Genom"},{"key":"9625_CR16","doi-asserted-by":"crossref","unstructured":"Azadbakht N, Doosti A, Jami MS. CRISPR\/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes. Biol Proced Online. 2022;24(1):8.","DOI":"10.1186\/s12575-022-00171-1"},{"issue":"38","key":"9625_CR17","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1016\/j.vaccine.2011.06.099","volume":"29","author":"KY Liu","year":"2011","unstructured":"Liu KY, Shi Y, Luo P. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model. Vaccine. 2011;29(38):6679\u201385.","journal-title":"Vaccine"},{"issue":"11","key":"9625_CR18","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.3390\/ijms19113605","volume":"19","author":"D Hobernik","year":"2018","unstructured":"Hobernik D, Bros M. DNA vaccines\u2014how far from clinical use? Int J Mol Sci. 2018;19(11):3605.","journal-title":"Int J Mol Sci"},{"issue":"36","key":"9625_CR19","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1016\/j.vaccine.2009.05.009","volume":"27","author":"WY Zhou","year":"2009","unstructured":"Zhou WY, Shi Y, Wu C, Zhang WJ, Mao XH, Guo G, Zou QM. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB\/c mice model. Vaccine. 2009;27(36):5013\u20139.","journal-title":"Vaccine"},{"issue":"80","key":"9625_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","volume":"15","author":"J Lee","year":"2018","unstructured":"Lee J, Kumar SA, Jhan YY, Bishop CJ. Engineering DNA vaccines against infectious diseases. Acta Biomater. 2018;15(80):31\u201347.","journal-title":"Acta Biomater"},{"issue":"1","key":"9625_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-021-00424-2","volume":"7","author":"C Kim","year":"2022","unstructured":"Kim C, Hovakimyan A, Zagorski K, Antonyan T, Petrushina I, Davtyan H, Agadjanyan MG. Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human \u03b1-synuclein: prelude for IND enabling studies. NPJ Vaccines. 2022;7(1):1.","journal-title":"NPJ Vaccines"},{"issue":"1","key":"9625_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12865-024-00602-6","volume":"25","author":"A Kaveh-Samani","year":"2024","unstructured":"Kaveh-Samani A, Dalali S, Kaviani F, Piri-Gharaghie T, Doosti A. Oral administration of DNA alginate nanovaccine induced immune-protection against Helicobacter pylori in Balb\/C mice. BMC Immunol. 2024;25(1):11.","journal-title":"BMC Immunol"},{"issue":"6","key":"9625_CR23","doi-asserted-by":"publisher","first-page":"e12428","DOI":"10.1111\/hel.12428","volume":"22","author":"L Guo","year":"2017","unstructured":"Guo L, Yin R, Xu G, Gong X, Chang Z, Hong D, Liu K. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils. Helicobacter. 2017;22(6):e12428.","journal-title":"Helicobacter"},{"issue":"6","key":"9625_CR24","doi-asserted-by":"publisher","first-page":"e0131364","DOI":"10.1371\/journal.pone.0131364","volume":"10","author":"I Bosschem","year":"2015","unstructured":"Bosschem I, Bayry J, De Bruyne E, Van Deun K, Smet A, Vercauteren G, Flahou B. Effect of different adjuvants on protection and side-effects induced by Helicobacter suis whole-cell lysate vaccination. PloS One. 2015;10(6):e0131364.","journal-title":"PloS One."},{"issue":"5","key":"9625_CR25","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/1040841X.2017.1291578","volume":"43","author":"N Mirzaei","year":"2017","unstructured":"Mirzaei N, Poursina F, Moghim S, Rashidi N, GhasemianSafaei H. The study of H pylori putative candidate factors for single-and multi-component vaccine development. Crit Rev Microbiol. 2017;43(5):631\u201350.","journal-title":"Crit Rev Microbiol"},{"issue":"6","key":"9625_CR26","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1128\/CVI.00492-07","volume":"15","author":"CC Wilson","year":"2008","unstructured":"Wilson CC, Newman MJ, Livingston BD, MaWhinney S, Forster JE, Scott J, Benson CA. Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy. Clin Vaccine Immunol. 2008;15(6):986\u201394.","journal-title":"Clin Vaccine Immunol"},{"issue":"17\u201318","key":"9625_CR27","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.vaccine.2005.01.059","volume":"23","author":"AS De Groot","year":"2005","unstructured":"De Groot AS, McMurry J, Marcon L, Franco J, Rivera D, Kutzler M, Martin B. Developing an epitope-driven tuberculosis (TB) vaccine. Vaccine. 2005;23(17\u201318):2121\u201331.","journal-title":"Vaccine"},{"key":"9625_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.micpath.2018.01.040","volume":"116","author":"A Jafarzadeh","year":"2018","unstructured":"Jafarzadeh A, Larussa T, Nemati M, Jalapour S. T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection. Microb Pathog. 2018;116:227\u201336.","journal-title":"Microb Pathog"},{"issue":"4","key":"9625_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00054725-199911000-00009","volume":"5","author":"S Romagnani","year":"1999","unstructured":"Romagnani S. Th1\/th2 cells. Inflamm Bowel Dis. 1999;5(4):285\u201394.","journal-title":"Inflamm Bowel Dis"},{"key":"9625_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micpath.2018.06.033","volume":"123","author":"N Bagheri","year":"2018","unstructured":"Bagheri N, Salimzadeh L, Shirzad H. The role of T helper 1-cell response in Helicobacter pylori-infection. Microb Pathog. 2018;123:1\u20138.","journal-title":"Microb Pathog"},{"issue":"9","key":"9625_CR31","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.4049\/jimmunol.0901115","volume":"184","author":"Y Shi","year":"2010","unstructured":"Shi Y, Liu XF, Zhuang Y, Zhang JY, Liu T, Yin Z, Zou QM. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol. 2010;184(9):5121\u20139.","journal-title":"J Immunol"},{"issue":"6","key":"9625_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/sji.12175","volume":"79","author":"PA Bretscher","year":"2014","unstructured":"Bretscher PA. On the mechanism determining the TH1\/TH2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment, of certain infectious diseases. Scand J Immunol. 2014;79(6):361\u201376.","journal-title":"Scand J Immunol"},{"issue":"19","key":"9625_CR33","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.3748\/wjg.v20.i19.5583","volume":"20","author":"M Moyat","year":"2014","unstructured":"Moyat M, Velin D. Immune responses to Helicobacter pylori infection. World J Gastroenterol WJG. 2014;20(19):5583.","journal-title":"World J Gastroenterol WJG"},{"issue":"1","key":"9625_CR34","doi-asserted-by":"publisher","first-page":"2105102","DOI":"10.1080\/19490976.2022.2105102","volume":"14","author":"SD Dooyema","year":"2022","unstructured":"Dooyema SD, Noto JM, Wroblewski LE, Piazuelo MB, Krishna U, Suarez G, Peek RM. Helicobacter pylori actively suppresses innate immune nucleic acid receptors. Gut Microbes. 2022;14(1):2105102.","journal-title":"Gut Microbes."},{"issue":"1","key":"9625_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1046\/j.1440-1711.2000.00881.x","volume":"78","author":"P Sutton","year":"2000","unstructured":"Sutton P, Wilson J, Kosaka T, Wolowczuk I, Lee A. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies. Immunol Cell Biol. 2000;78(1):28\u201330.","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"9625_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/ijms24010091","volume":"24","author":"HW Fu","year":"2022","unstructured":"Fu HW, Lai YC. The role of Helicobacter pylori neutrophil-activating protein in the pathogenesis of H pylori and beyond: from a virulence factor to therapeutic targets and therapeutic agents. Int J Mol Sci. 2022;24(1):91.","journal-title":"Int J Mol Sci."},{"issue":"3","key":"9625_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1574-695X.2009.00566.x","volume":"56","author":"Q Gu","year":"2009","unstructured":"Gu Q, Song D, Zhu M. Oral vaccination of mice against Helicobacter pylori with recombinant Lactococcus lactis expressing urease subunit B. FEMS Immunol Med Microbiol. 2009;56(3):197\u2013203.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"9625_CR38","unstructured":"Underwood W, Anthony R. 2020 AVMA guidelines for the euthanasia of animals: 2020 edition. Retrieved on March. Mar;2013(30):2020\u20131"},{"issue":"20","key":"9625_CR39","doi-asserted-by":"publisher","first-page":"100395","DOI":"10.1016\/j.iotech.2023.100395","volume":"1","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang H. Lymph node targeting for immunotherapy. Immuno-Oncol Technol. 2023;1(20):100395.","journal-title":"Immuno-Oncol Technol"},{"issue":"4","key":"9625_CR40","first-page":"254","volume":"27","author":"S Tufail","year":"2013","unstructured":"Tufail S, Badrealam KF, Sherwani A, Gupta UD, Owais M. Tissue specific heterogeneity in effector immune cell response. Front Immunol. 2013;27(4):254.","journal-title":"Front Immunol"},{"issue":"5","key":"9625_CR41","first-page":"488","volume":"7","author":"V Brucklacher-Waldert","year":"2014","unstructured":"Brucklacher-Waldert V, Carr EJ, Linterman MA, Veldhoen M. Cellular plasticity of CD4+ T cells in the intestine. Front Immunol. 2014;7(5):488.","journal-title":"Front Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09625-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09625-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09625-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:31:06Z","timestamp":1770190266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09625-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9625"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09625-6","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agree to publish.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This article does not contain any studies with human participants. The study was approved by the Ethics Committee of the Islamic Azad University of Shahrekord Branch in Iran (IR.IAU.SHK.REC.1401).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}